Cadence Bank’s AbbVie ABBV Stock Holding History

Cadence Bank’s Portfolio ABBV Stock Details ABBV Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$11.7M	Sell	63,270 -39,083	-38%	-$7.25M	0.77%	26
2025 Q1	$21.4M	Buy	102,353 +1,063	+1%	+$223K	1.53%	13
2024 Q4	$18M	Buy	101,290 +1,208	+1%	+$215K	1.22%	16
2024 Q3	$19.8M	Buy	100,082 +688	+0.7%	+$136K	1.36%	15
2024 Q2	$17M	Sell	99,394 -2,704	-3%	-$464K	1.28%	14
2024 Q1	$18.6M	Sell	102,098 -875	-0.8%	-$159K	1.35%	16
2023 Q4	$16M	Sell	102,973 -498	-0.5%	-$77.2K	1.3%	15
2023 Q3	$15.4M	Sell	103,471 -1,287	-1%	-$192K	1.36%	13
2023 Q2	$14.1M	Buy	104,758 +5,698	+6%	+$768K	1.23%	14
2023 Q1	$15.8M	Buy	99,060 +736	+0.7%	+$117K	1.45%	14
2022 Q4	$15.9M	Buy	98,324 +1,051	+1%	+$170K	1.47%	12
2022 Q3	$13.1M	Buy	97,273 +16,415	+20%	+$2.2M	1.35%	12
2022 Q2	$12.4M	Sell	80,858 -1,071	-1%	-$164K	1.78%	9
2022 Q1	$13.3M	Sell	81,929 -11,256	-12%	-$1.82M	1.65%	13
2021 Q4	$12.6M	Buy	93,185 +973	+1%	+$132K	1.57%	13
2021 Q3	$9.95M	Buy	92,212 +313	+0.3%	+$33.8K	1.39%	15
2021 Q2	$10.4M	Buy	91,899 +1,112	+1%	+$125K	1.5%	14
2021 Q1	$9.83M	Sell	90,787 -1,070	-1%	-$116K	1.49%	14
2020 Q4	$9.84M	Buy	91,857 +5,568	+6%	+$597K	1.54%	11
2020 Q3	$7.56M	Sell	86,289 -1,047	-1%	-$91.7K	1.49%	17
2020 Q2	$8.58M	Buy	87,336 +2,118	+2%	+$208K	1.77%	9
2020 Q1	$6.49M	Buy	85,218 +4,212	+5%	+$321K	1.64%	10
2019 Q4	$7.17M	Buy	81,006 +316	+0.4%	+$28K	1.33%	12
2019 Q3	$6.11M	Buy	80,690 +33,869	+72%	+$2.56M	0.58%	25
2019 Q2	$3.41M	Buy	46,821 +3,466	+8%	+$252K	0.33%	56
2019 Q1	$3.49M	Buy	43,355 +770	+2%	+$62.1K	0.35%	50
2018 Q4	$3.93M	Buy	42,585 +2,382	+6%	+$220K	0.46%	34
2018 Q3	$3.8M	Buy	40,203 +366	+0.9%	+$34.6K	0.35%	42
2018 Q2	$3.69M	Buy	39,837 +13,321	+50%	+$1.23M	0.33%	43
2018 Q1	$2.51M	Buy	26,516 +362	+1%	+$34.3K	0.24%	58
2017 Q4	$2.53M	Buy	+26,154	New	+$2.53M	0.24%	59